Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 54.35%18.73B | 17.95%12.13B | 44.99%4.49B | 21.65%2.68B | -8.16%2.39B | 7.92%2.57B | -5.32%10.29B | 10.58%3.1B | 6.79%2.2B | -17.68%2.6B |
| Cost of revenue | 62.71%15.19B | 17.54%9.34B | 47.11%3.41B | 18.76%2.03B | -8.19%1.83B | 7.57%2.07B | -6.89%7.94B | 10.61%2.32B | 9.41%1.71B | -21.05%2B |
| Gross profit | 26.42%3.53B | 19.35%2.79B | 38.71%1.09B | 31.73%645.67M | -8.06%557.62M | 9.37%503.94M | 0.43%2.34B | 10.49%783.39M | -1.44%490.14M | -4.21%606.53M |
| Operating expense | 8.64%2.42B | 4.91%2.23B | 4.75%570.74M | 4.86%569.38M | 4.52%522.45M | 5.50%562.91M | 1.89%2.12B | -0.52%544.87M | 3.86%543M | 2.80%499.86M |
| Staff costs | 8.13%1.57B | 6.24%1.45B | 9.76%549.57M | 5.46%317.53M | 4.29%292.59M | 2.74%287.88M | 2.76%1.36B | 0.99%500.69M | 1.75%301.09M | 2.52%280.56M |
| Selling and administrative expenses | 16.94%156.64M | 1.21%133.95M | ---- | ---- | ---- | ---- | 54.25%132.34M | ---- | ---- | ---- |
| -Selling and marketing expense | 35.98%29.05M | -38.56%21.37M | ---- | ---- | ---- | ---- | 82.96%34.77M | ---- | ---- | ---- |
| -General and administrative expense | 13.33%127.59M | 15.39%112.58M | ---- | ---- | ---- | ---- | 46.08%97.57M | ---- | ---- | ---- |
| Depreciation and amortization | 17.14%39.58M | -39.55%33.79M | ---- | ---- | ---- | ---- | -18.05%55.9M | ---- | ---- | ---- |
| -Depreciation | 17.14%39.58M | -9.42%33.79M | ---- | ---- | ---- | ---- | -6.86%37.31M | ---- | ---- | ---- |
| -Amortization | ---- | --0 | ---- | ---- | ---- | ---- | -33.97%18.59M | ---- | ---- | ---- |
| Rent and land expenses | 8.98%133.97M | -0.46%122.93M | ---- | ---- | ---- | ---- | -13.34%123.5M | ---- | ---- | ---- |
| Other operating expenses | 7.21%522.38M | 9.00%487.25M | -0.72%-269.49M | 4.11%251.86M | 4.82%229.86M | 8.54%275.03M | -2.72%447.04M | -9.38%-267.56M | 6.61%241.92M | 3.15%219.3M |
| Operating profit | 96.06%1.11B | 158.89%568.36M | 116.28%515.86M | 244.31%76.29M | -67.03%35.17M | 18.99%-58.97M | -11.80%219.54M | 47.86%238.52M | -107.24%-52.87M | -27.41%106.67M |
| Net non-operating interest income (expenses) | -148.44%-10.4M | -4.28%-4.19M | 1,120.25%1.93M | 103.08%67K | -4,157.89%-4.63M | 26.43%-1.56M | 5.86%-4.02M | -61.27%158K | -197.93%-2.17M | 102.64%114K |
| Non-operating interest income | 2,003.53%1.79M | -50.87%85K | -91.67%6K | -93.06%5K | -45.83%13K | 1,120.00%61K | 592.00%173K | 1,100.00%72K | 1,100.00%72K | 242.86%24K |
| Non-operating interest expense | 185.35%12.19M | 2.01%4.27M | -2,134.88%-1.92M | -102.76%-62K | 5,254.44%4.64M | -23.73%1.62M | -2.38%4.19M | 78.61%-86K | 201.45%2.24M | -102.08%-90K |
| Net investment income | 127.68%9.43M | -3.81%4.14M | 201.32%2.73M | 589.05%4.4M | -273.83%-3.05M | -94.43%56K | 111.47%4.3M | 99.12%906K | -25.70%639K | 104.34%1.75M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -24.83M | 0 | 0 | 0 | -80.46M | 0 | ||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 0 | 65.14%-1.63M | 0 | 0 | 50.56%-4.68M | -716.69%-4.69M | -238.64%-61K | |||
| Less:Other special charges | ---- | -65.14%1.63M | --0 | --0 | ---- | ---- | -50.56%4.68M | ---- | ---- | ---- |
| Less:Write off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 569.23%61K | ---- |
| Other non-operating income (expenses) | -80.62%-93.95M | -8,041.68%-52.02M | -30,225.71%-52.72M | -185.21%-265K | 48.15%-14K | 400.51%981K | 123.68%655K | 112.95%175K | 294.38%311K | 96.96%-27K |
| Income before tax | 93.24%994.53M | 280.26%514.66M | 99.01%467.8M | 159.80%80.49M | -76.20%25.85M | 19.29%-59.48M | -30.56%135.34M | 45.47%235.06M | -496.97%-134.61M | 7.28%108.59M |
| Income tax | 145.44%323.71M | 92.81%131.89M | 369.20%45.47M | 50.13%45.58M | 156.81%8.2M | -52.95%32.64M | 23.84%68.4M | 3.52%-16.89M | 451.81%30.36M | -178.43%-14.44M |
| Net income | 75.25%670.82M | 471.82%382.77M | 67.63%422.33M | 121.17%34.92M | -85.66%17.64M | 35.61%-92.13M | -52.07%66.94M | 40.69%251.95M | -1,085.18%-164.97M | 48.55%123.03M |
| Net income continuous operations | 75.25%670.82M | 471.81%382.77M | 67.63%422.33M | 121.17%34.92M | -85.66%17.64M | 35.61%-92.13M | -52.07%66.94M | 40.69%251.95M | -1,085.16%-164.96M | 48.55%123.03M |
| Noncontrolling interests | 9.56M | 0 | ||||||||
| Net income attributable to the company | 72.76%661.26M | 471.82%382.77M | 67.63%422.33M | 121.17%34.92M | -85.66%17.64M | 35.61%-92.13M | -52.07%66.94M | 40.69%251.95M | -1,085.18%-164.97M | 48.55%123.03M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 72.76%661.26M | 471.82%382.77M | 67.63%422.33M | 121.17%34.92M | -85.66%17.64M | 35.61%-92.13M | -52.07%66.94M | 40.69%251.95M | -1,085.18%-164.97M | 48.55%123.03M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 72.75%43.74 | 471.56%25.32 | 67.61%27.94 | 121.17%2.31 | -85.73%1.16 | 35.62%-6.09 | -52.06%4.43 | 40.68%16.67 | -1,085.87%-10.91 | 48.63%8.13 |
| Diluted earnings per share | 72.75%43.74 | 471.56%25.32 | 67.63%27.9331 | 121.17%2.3095 | -85.73%1.16 | 35.62%-6.09 | -52.06%4.43 | 40.69%16.6636 | -1,085.18%-10.9106 | 48.63%8.13 |
| Dividend per share | 20.00%6 | 66.67%5 | 66.67%5 | 0 | 0 | 0 | 0.00%3 | 0.00%3 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |